Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 971

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction

Oates, John A., Wood, Alastair J.J., Benowitz, Neal L.·1988·New England Journal of Medicine
DOI 10.1056/nejm198811173192005
Open this paper in CoChat — free account

Abstract

NICOTINE has been consumed in the form of tobacco and other plants for many hundreds of years. The compulsive use of tobacco has been observed in nearly every culture into which tobacco has been introduced. Nearly 30 percent of adult Americans smoke despite, in most cases, a desire to quit and despite common knowledge of the health hazards.1 Their failure to quit smoking is attributable in large part to the addictive properties of nicotine. Recently, nicotine has become available as a pharmaceutical agent, marketed as a chewing gum to help people stop smoking. In addition to its direct effect on . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm198811173192005

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 151

  1. 1987, MMWR, 36, 581
  2. Benowitz, 1983, Clin Pharmacol Ther, 34, 604, 10.1038/clpt.1983.222 · DOI · Paper page
  3. Pool, 1985, Toxicologist, 5, 232
  4. Hansson, 1962, J Pharmacol Exp Ther, 137, 91, 10.1016/S0022-3565(25)26329-7 · DOI
  5. Spector, 1982, J Neurochem, 38, 594, 10.1111/j.1471-4159.1982.tb08669.x · DOI
  6. Clarke, 1984, Brain Res, 323, 390, 10.1016/0006-8993(84)90320-2 · DOI · Paper page
  7. London, 1985, Neurosci Lett, 53, 179, 10.1016/0304-3940(85)90182-X · DOI
  8. Clarke, 1985, Brain Res, 348, 355, 10.1016/0006-8993(85)90456-1 · DOI · Paper page
  9. London, 1985, Eur J Pharmacol, 110, 391, 10.1016/0014-2999(85)90572-2 · DOI
  10. Balfour, 1982, Pharmacol Ther, 16, 269, 10.1016/0163-7258(82)90058-4 · DOI · Paper page
  11. Chesselet, 1984, Neuroscience, 12, 347, 10.1016/0306-4522(84)90058-7 · DOI · Paper page
  12. Clarke, 1987, Psychopharmacology, 92, 135
  13. Ginzel, 1975, NaunynSchmiedebergs Arch Pharmacol, 288, 29, 10.1007/BF00501812 · doi:10.1007/bf00501812
  14. Comroe, 1960, Ann NY Acad Sci, 90, 48, 10.1111/j.1749-6632.1960.tb32616.x · doi:10.1111/j.1749-6632.1960.tb32616.x
  15. Nedergaard, 1977, Eur J Pharmacol, 42, 315, 10.1016/0014-2999(77)90165-0 · doi:10.1016/0014-2999(77)90165-0
  16. Su, 1982, Pharmacol Ther, 17, 129, 10.1016/0163-7258(82)90050-X · DOI
  17. Marks, 1985, J Pharmacol Exp Ther, 235, 619
  18. West, 1987, Psychopharmacology (Berlin), 92, 118, 10.1007/BF00215491 · DOI
  19. Benowitz, 1987, Clin Pharmacol Ther, 42, 119, 10.1038/clpt.1987.119 · DOI
  20. Knott, 1977, Psychopharmacology (Berlin), 14, 150
  21. Lukas, 1983, Fed Proc, 42, 1018
  22. Warburton DM. The functions of smoking. In: Martin WR, Van Loon GR, Iwamoto ET, Davis L, eds. Advances in behavioral biology. Vol. 31. Tobacco smoking and nicotine: a neurobiological approach. New York: Plenum Press, 1987:51–61.
  23. Wesnes, 1983, Pharmacol Ther, 21, 189, 10.1016/0163-7258(83)90072-4 · DOI · Paper page
  24. Nicod, 1984, J Am Coll Cardiol, 4, 964, 10.1016/S0735-1097(84)80058-3 · DOI
  25. Freund, 1960, Ann NY Acad Sci, 90, 85, 10.1111/j.1749-6632.1960.tb32621.x · DOI
  26. Eckstein, 1960, Ann NY Acad Sci, 90, 133, 10.1111/j.1749-6632.1960.tb32625.x · DOI · Paper page
  27. Rottenstein, 1960, Ann NY Acad Sci, 90, 102, 10.1111/j.1749-6632.1960.tb32622.x · DOI · Paper page
  28. Waeber, 1984, Am J Physiol, 247, H895
  29. Green, 1986, Am Heart J, 111, 932, 10.1016/0002-8703(86)90645-9 · DOI · Paper page
  30. Sonnenfeld, 1980, Br J Pharmacol, 71, 609, 10.1111/j.1476-5381.1980.tb10980.x · DOI
  31. Wennmalm, 1980, Br J Pharmacol, 69, 545, 10.1111/j.1476-5381.1980.tb07901.x · DOI
  32. Alster, 1983, Acta Physiol Scand, 117, 581, 10.1111/j.1748-1716.1983.tb07230.x · doi:10.1111/j.1748-1716.1983.tb07230.x
  33. Nadler, 1983, Lancet, 1, 1248, 10.1016/S0140-6736(83)92698-3 · DOI · Paper page
  34. Nowak, 1987, Circulation, 76, 6, 10.1161/01.CIR.76.1.6 · DOI · Paper page
  35. Benowitz, 1982, J Pharmacol Exp Ther, 221, 368, 10.1016/S0022-3565(25)33068-5 · DOI · Paper page
  36. Rosenberg, 1980, Clin Pharmacol Ther, 28, 516, 10.1038/clpt.1980.196 · DOI
  37. Porchet, 1988, J Pharmacol Exp Ther, 244, 231, 10.1016/S0022-3565(25)24269-0 · DOI · Paper page
  38. Schulz, 1986, N Engl J Med, 314, 1639, 10.1056/NEJM198606193142510 · DOI
  39. Benowitz, 1982, Clin Pharmacol Ther, 32, 758, 10.1038/clpt.1982.233 · DOI · Paper page
  40. Seyler, 1986, Pharmacol Biochem Behav, 24, 159, 10.1016/0091-3057(86)90062-6 · DOI
  41. Wilkins, 1982, Psychopharmacology (Berlin), 78, 305, 10.1007/BF00433730 · DOI · Paper page
  42. Benowitz, 1984, Clin Pharmacol Ther, 36, 74, 10.1038/clpt.1984.142 · DOI · Paper page
  43. McKinlay, 1985, Ann Intern Med, 103, 350, 10.7326/0003-4819-103-3-350 · DOI · Paper page
  44. Jensen, 1985, N Engl J Med, 313, 973, 10.1056/NEJM198510173131602 · DOI · Paper page
  45. Barbieri, 1986, Fertil Steril, 46, 232, 10.1016/S0015-0282(16)49517-8 · DOI · Paper page
  46. Wack, 1982, Am J Clin Nutr, 35, 366, 10.1093/ajcn/35.2.366 · DOI · Paper page
  47. Grunberg, 1982, Addict Behav, 7, 317, 10.1016/0306-4603(82)90001-6 · DOI · Paper page
  48. Fagerstrom, 1987, Addict Behav, 12, 91, 10.1016/0306-4603(87)90015-3 · DOI
  49. Dallosso, 1984, Int J Obes, 8, 365
  50. Hofstetter, 1986, N Engl J Med, 314, 79, 10.1056/NEJM198601093140204 · DOI · Paper page
  51. Carney, 1984, N Engl J Med, 310, 614, 10.1056/NEJM198403083101002 · DOI
  52. Sandberg, 1973, J Pharmacol Exp Ther, 184, 787, 10.1016/S0022-3565(25)29471-X · DOI
  53. Domino, 1969, Clin Pharmacol Ther, 10, 72, 10.1002/cpt196910172 · DOI
  54. Fagerstrom, 1977, Addict Behav, 2, 203, 10.1016/0306-4603(77)90018-1 · DOI
  55. Gori, 1986, Pharmacol Biochem Behav, 25, 1181, 10.1016/0091-3057(86)90108-5 · DOI
  56. McNabb, 1984, Can Med Assoc J, 131, 589
  57. Benowitz, 1987, Clin Pharmacol Ther, 41, 467, 10.1038/clpt.1987.58 · DOI · Paper page
  58. Zacny, 1986, Pharmacol Biochem Behav, 25, 1245, 10.1016/0091-3057(86)90119-X · DOI
  59. Benowitz, 1984, Clin Pharmacol Ther, 35, 499, 10.1038/clpt.1984.67 · DOI · Paper page
  60. Armitage, 1975, Br Med J, 4, 313, 10.1136/bmj.4.5992.313 · DOI · Paper page
  61. Feyerabend, 1985, Br J Clin Pharmacol, 19, 239, 10.1111/j.1365-2125.1985.tb02637.x · DOI · Paper page
  62. Luck, 1984, N Engl J Med, 311, 672, 10.1056/NEJM198409063111014 · DOI
  63. Petrakis, 1978, Science, 199, 303, 10.1126/science.619458 · DOI
  64. Luck, 1987, Eur J Pediatr, 146, 21, 10.1007/BF00647276 · DOI
  65. Benowitz, 1985, J Pharmacol Exp Ther, 234, 153, 10.1016/S0022-3565(25)23322-5 · DOI
  66. Neurath, 1987, Int Arch Occup Environ Health, 59, 199, 10.1007/BF00378497 · DOI
  67. Russell, 1981, Br Med J, 283, 814, 10.1136/bmj.283.6295.814 · DOI
  68. Turner, 1977, Br Med J, 2, 1387, 10.1136/bmj.2.6099.1387 · DOI
  69. Wald, 1984, Thorax, 39, 365, 10.1136/thx.39.5.365 · DOI
  70. Wald, 1981, Lancet, 2, 775, 10.1016/S0140-6736(81)90187-2 · DOI
  71. Saxena, 1985, Vet Hum Toxicol, 27, 495
  72. Gehlbach, 1974, JAMA, 229, 1880, 10.1001/jama.1974.03230520022024 · doi:10.1001/jama.1974.03230520022024
  73. Benowitz, 1986, Annu Rev Med, 37, 21, 10.1146/annurev.me.37.020186.000321 · DOI · Paper page
  74. Aronow, 1974, Circulation, 50, 340, 10.1161/01.CIR.50.2.340 · DOI
  75. Jain, 1977, Am J Cardiol, 39, 27, 10.1016/S0002-9149(77)80006-4 · doi:10.1016/s0002-9149(77)80006-4
  76. Kaijser, 1985, Clin Physiol, 5, 541, 10.1111/j.1475-097X.1985.tb00767.x · DOI
  77. Bayer, 1985, Therapiewoche, 35, 1968
  78. Maouad, 1984, Am J Cardiol, 53, 354, 10.1016/0002-9149(84)90464-8 · DOI
  79. FitzGerald, 1988, Am Heart J, 115, 267, 10.1016/0002-8703(88)90648-5 · DOI · Paper page
  80. Billimoria, 1975, Atherosclerosis, 21, 61, 10.1016/0021-9150(75)90094-5 · DOI
  81. Meade, 1980, Lancet, 1, 1050, 10.1016/S0140-6736(80)91498-1 · DOI · Paper page
  82. Belch, 1984, Thromb Haemost, 51, 6, 10.1055/s-0038-1660996 · DOI
  83. Siess, 1982, Circulation, 66, 44, 10.1161/01.CIR.66.1.44 · DOI
  84. Mustard, 1963, Br Med J, 1, 846, 10.1136/bmj.1.5334.846 · DOI
  85. Saba, 1975, Thromb Res, 7, 819, 10.1016/0049-3848(75)90207-8 · doi:10.1016/0049-3848(75)90207-8
  86. Renaud, 1984, Clin Pharmacol Ther, 36, 389, 10.1038/clpt.1984.193 · DOI
  87. Booyse, 1981, Am J Pathol, 102, 229
  88. Zimmerman, 1987, Atherosclerosis, 63, 33, 10.1016/0021-9150(87)90079-7 · DOI
  89. Davis, 1985, Clin Pharmacol Ther, 37, 529, 10.1038/clpt.1985.83 · DOI
  90. Stewart, 1985, Br Heart J, 54, 222, 10.1136/hrt.54.2.222 · DOI
  91. Rigotti, 1986, JAMA, 255, 1018, 10.1001/jama.1986.03370080040015 · DOI
  92. Isles, 1979, Br Med J, 1, 579, 10.1136/bmj.1.6163.579 · DOI
  93. Downey, 1981, J Pharmacol Exp Ther, 216, 363, 10.1016/S0022-3565(25)32428-6 · doi:10.1016/s0022-3565(25)32428-6
  94. McPhaul, 1984, JAMA, 252, 2860, 10.1001/jama.1984.03350200046020 · DOI
  95. Hoffmann, 1985, Cancer Lett, 26, 67, 10.1016/0304-3835(85)90174-0 · DOI
  96. Hatsukami, 1984, Psychopharmacology (Berlin), 84, 231, 10.1007/BF00427451 · DOI · Paper page
  97. Herning, 1983, Psychophysiology, 20, 507, 10.1111/j.1469-8986.1983.tb03004.x · DOI
  98. Hatsukami, 1987, Clin Pharmacol Ther, 41, 103, 10.1038/clpt.1987.17 · DOI
  99. Hughes, 1986, JAMA, 255, 3277, 10.1001/jama.1986.03370230083036 · DOI
  100. Hughes, 1984, Psychopharmacology (Berlin), 83, 82, 10.1007/BF00427428 · DOI · Paper page
  101. Herning, 1981, Br Med J, 283, 187, 10.1136/bmj.283.6285.187 · DOI · Paper page
  102. Benowitz, 1986, JAMA, 256, 241, 10.1001/jama.1986.03380020103032 · DOI
  103. Benowitz, 1983, N Engl J Med, 309, 139, 10.1056/NEJM198307213090303 · DOI · Paper page
  104. Gori, 1985, Regul Toxicol Pharmacol, 5, 314, 10.1016/0273-2300(85)90045-5 · DOI
  105. Benowitz, 1986, N Engl J Med, 315, 1310, 10.1056/NEJM198611203152102 · DOI · Paper page
  106. Lucchesi, 1967, Clin Pharmacol Ther, 8, 789, 10.1002/cpt196786789 · DOI
  107. Young, 1981, J Toxicol Environ Health, 7, 801, 10.1080/15287398109530021 · doi:10.1080/15287398109530021
  108. Kaufman, 1983, N Engl J Med, 308, 409, 10.1056/NEJM198302243080801 · DOI
  109. Orleans, 1985, Annu Rev Med, 36, 51, 10.1146/annurev.me.36.020185.000411 · DOI
  110. Edwards, 1982, Br J Addict, 77, 3, 10.1111/j.1360-0443.1982.tb03246.x · DOI
  111. Henningfield JE, London ED, Jaffe JH. Nicotine reward: studies of abuse liability and physical dependence potential. In: Engel J, Oreland L, eds. Brain reward systems and abuse: Seventh International Berzelius Symposium. New York: Raven Press, 1987:147–64.
  112. Henningfield, 1985, J Pharmacol Exp Ther, 234, 1, 10.1016/S0022-3565(25)23319-5 · DOI · Paper page
  113. Henningfield, 1983, Pharmacol Biochem Behav, 19, 989, 10.1016/0091-3057(83)90405-7 · DOI · Paper page
  114. Henningfield, 1979, Behav Res Methods Instrum, 11, 538, 10.3758/BF03201375 · DOI
  115. Henningfield JE. How tobacco produces drug dependence. In: Ockene JK, ed. The pharmacologic treatment of tobacco dependence: proceedings of the world congress, November 4–5, 1985. Cambridge, Mass.: Institute for the Study of Smoking Behavior and Policy, 1986; 19–31.
  116. Hunt, 1971, J Clin Psychol, 27, 455, 10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R · doi:10.1002/1097-4679(197110)27:4<455::aid-jclp2270270412>3.0.co;2-r
  117. Russell, 1983, Br Med J, 287, 1782, 10.1136/bmj.287.6407.1782 · DOI · Paper page
  118. 1986, Ann Intern Med, 105, 281, 10.7326/0003-4819-105-2-281 · DOI
  119. Stolerman, 1973, Psychopharmacologia, 28, 247, 10.1007/BF00429305 · DOI · Paper page
  120. Tennant FS, Tarver AL. Withdrawal from nicotine dependence using mecamylamine: comparison of three-week and six-week dosage schedules. In: Harris LS, ed. Problems of drug dependence, 1984: proceedings of the 46th Annual Scientific Meeting, the Committee on Problems of Drug Dependence, Inc. NIDA research monograph 55. Rockville, Md.: Department of Health and Human Services, National Institute on Drug Abuse, 1985:291–7.
  121. Glassman, 1984, Science, 226, 864, 10.1126/science.6387913 · DOI · Paper page
  122. Jarvis, 1987, Br J Addict, 82, 983, 10.1111/j.1360-0443.1987.tb01558.x · DOI
  123. Rose, 1985, Clin Pharmacol Ther, 38, 450, 10.1038/clpt.1985.203 · DOI
  124. Russell, 1976, Br Med J, 1, 1043, 10.1136/bmj.1.6017.1043 · DOI · Paper page
  125. Hughes, 1984, JAMA, 252, 2855, 10.1001/jama.1984.03350200041018 · DOI
  126. Lam, 1987, Lancet, 2, 27, 10.1016/S0140-6736(87)93061-3 · DOI · Paper page
  127. Tønnesen, 1988, N Engl J Med, 318, 15, 10.1056/NEJM198801073180104 · DOI · Paper page
  128. Crofton, 1983, Br Med J, 286, 595, 10.1136/bmj.286.6370.1051 · doi:10.1136/bmj.286.6370.1051
  129. Hughes JR. Dependence potential and abuse liability of nicotine replacement therapies. In: Progress in clinical and biological research. Vol. 261. Pomerleau OF, Pomerleau CS, eds. Nicotine replacement: a critical evaluation. New York: Alan R. Liss, 1988:261–77.
  130. Fleischmann, 1986, Eur J Clin Pharmacol, 30, 475, 10.1007/BF00607963 · doi:10.1007/bf00607963
  131. Ali, 1980, Biochem Pharmacol, 29, 3087, 10.1016/0006-2952(80)90450-5 · doi:10.1016/0006-2952(80)90450-5
  132. Lee, 1987, Ann Intern Med, 106, 553, 10.7326/0003-4819-106-4-553 · DOI
  133. Roth, 1976, J Pharmacol Exp Ther, 199, 53, 10.1016/S0022-3565(25)30655-5 · doi:10.1016/s0022-3565(25)30655-5
  134. Jusko WJ. Smoking effects in pharmacokinetics. In: Benet LZ, Massoud N, Gambertoglio JG, eds. Pharmacokinetic basis for drug treatment. New York: Raven Press, 1984:311–20.
  135. Powell, 1977, Am Rev Respir Dis, 116, 17
  136. Pfeifer, 1978, Chest, 73, 455, 10.1378/chest.73.4.455 · doi:10.1378/chest.73.4.455
  137. Norman, 1981, Eur J Clin Pharmacol, 21, 229, 10.1007/BF00627925 · DOI
  138. Walle, 1985, Clin Pharmacol Ther, 38, 509, 10.1038/clpt.1985.216 · DOI
  139. Vaughan, 1976, Br J Clin Pharmacol, 3, 279, 10.1111/j.1365-2125.1976.tb00604.x · DOI
  140. Klemp, 1982, Br Med J, 284, 237, 10.1136/bmj.284.6311.237 · DOI
  141. Trap-Jensen, 1979, Eur J Clin Invest, 9, 181, 10.1111/j.1365-2362.1979.tb00920.x · DOI
  142. Deanfield, 1984, N Engl J Med, 310, 951, 10.1056/NEJM198404123101504 · doi:10.1056/nejm198404123101504
  143. Dollery, 1988, Am Heart J, 115, 276, 10.1016/0002-8703(88)90650-3 · DOI
  144. Benowitz, 1988, Clin Pharmacol Ther, 43, 162
  145. Collaborative Group for the Study of Stroke in Young Women, 1975, JAMA, 231, 718, 10.1001/jama.1975.03240190022010 · DOI · Paper page
  146. Shapiro, 1979, Lancet, 1, 743, 10.1016/S0140-6736(79)91205-4 · DOI · Paper page
  147. 1973, N Engl J Med, 288, 277, 10.1056/NEJM197302082880602 · DOI · Paper page
  148. Swett, 1974, Arch Gen Psychiatry, 31, 211, 10.1001/archpsyc.1974.01760140063010 · DOI
  149. 1973, Clin Pharmacol Ther, 14, 259, 10.1002/cpt1973142259 · DOI
  150. Kikendall, 1984, J Clin Gastroenterol, 6, 65
  151. Lam, 1987, Gastroenterology, 92, 1193, 10.1016/S0016-5085(87)91077-8 · doi:10.1016/s0016-5085(87)91077-8

Cited by

See all 971

Metadata

Authors
Oates, J. A., Wood, A. J. J., & Benowitz, N. L.
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
1988-11-17
Volume
319
Issue
20
Pages
1318-1330
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
DOI
10.1056/nejm198811173192005
OpenAlex
W2328901850
Cited by
971
References
11
FWCI
15.38
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction. https://app.cochat.ai/papers/10.1056/nejm198811173192005
The paper
Oates, J. A., Wood, A. J. J., & Benowitz, N. L. (1988). Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction. New England Journal of Medicine. https://doi.org/10.1056/nejm198811173192005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.